Reproducibility of daptomycin MIC results using dry-form commercial trays with appropriate supplemental calcium content
- 31 March 2005
- journal article
- other
- Published by Elsevier in International Journal of Antimicrobial Agents
- Vol. 25 (3) , 274-275
- https://doi.org/10.1016/j.ijantimicag.2005.01.001
Abstract
No abstract availableThis publication has 6 references indexed in Scilit:
- Daptomycin: Another Novel Agent for Treating Infections Due to Drug‐Resistant Gram‐Positive PathogensClinical Infectious Diseases, 2004
- In Vitro Activity of Daptomycin against Gram-Positive European Clinical Isolates with Defined Resistance DeterminantsAntimicrobial Agents and Chemotherapy, 2004
- Daptomycin activity and spectrum: a worldwide sample of 6737 clinical Gram-positive organismsJournal of Antimicrobial Chemotherapy, 2004
- Validation of commercial dry-form broth microdilution panels for susceptibility testing of AZD2563, a new long-acting oxazolidinoneClinical Microbiology & Infection, 2003
- Global Epidemiology of Antimicrobial Resistance among Community-Acquired and Nosocomial Pathogens: A Five-Year Summary from the SENTRY Antimicrobial Surveillance Program (1997-2001)Seminars in Respiratory and Critical Care Medicine, 2003
- Daptomycin susceptibility tests: interpretive criteria, quality control, and effect of calcium on in vitro testsDiagnostic Microbiology and Infectious Disease, 2000